SOLS makes custom 3D-printed shoe insoles created from a mobile-app foot scan and processing algorithms that factor in height, weight, lifestyle and intended use. The company has focused on doctor-prescribed orthotics and has grown from dozens of prescribing doctors to over 300 medical professionals offering its products. SOLS has planned consumer-facing distribution and aims to address athletes’ needs with its custom inserts. The product pricing for resold insoles was cited in the $300–$700 range. The company added Dallas Mavericks president and CEO Terdema Ussery to its board and counts Carmelo Anthony as an investor. With the new round, SOLS has raised a total of $19.3 million to date. SOLS Systems produces 3D-printed dynamic orthotics using a proprietary computer vision system that converts images or brief videos into precise 3D models of the foot. The model, combined with patient body, lifestyle and medical-need data, is used to generate fully custom, precision-engineered orthotics. The company is preparing custom mass-manufacturing platforms to support a direct-to-consumer launch planned for 2015. It intends to use its new funding to accelerate team growth (the team is now 12 people) and product development. SOLS Systems was founded and is led by CEO Kegan Schouwenburg. The company previously closed a $1.75m seed round in December 2013. SOLS produces custom 3D-printed antimicrobial nylon insoles that are polished and coated for a soft, rubbery feel and offered in multiple colors and leather. Customers scan their feet with an iOS or Android app; SOLS combines that 3D scan with weight, lifestyle and use-case data to generate a bespoke insole. The company is initially targeting the medical market with a beta program of fifteen doctors and plans a consumer launch afterward. Patient pricing for the medical program is expected to be around $300–$500, with a goal to reduce consumer pricing to about $100 upon broader launch. SOLS plans partnerships with shoe manufacturers and retailers for in-store scanning and fit-to-shoe options, and expects to expand city-by-city after launching in New York. The company has raised seed funding to support product development and rollout, and ALM is a strategic partner on materials and production.

Total raised

$19M

Funding rounds

3

Latest round

Series B

Latest activity

Feb 2015